Marksans Pharma Limited announced today that UK MHRA has granted Market Authorisation to the Company’s wholly owned subsidiary Bell Sons & Co. (Druggists) Limited for Bells Healthcare All in One Oral Solution.
Each 20 ml dose contains Paracetamol Ph. Eur. 500.0 mg, Guaifenesin Ph. Eur. 200.0 mg and Phenylephrine Hydrochloride Ph. Eur. 10.0 mg.
Therapeutic use of the product is for short term symptomatic relief of colds, chills and influenza including chesty coughs.
Marksans will manufacture the products at its UK MHRA approved facility Bell Sons & Co. (Druggists) Limited in UK.